AI
MYOV

Atria Investments’s Myovant Sciences Ltd. MYOV Stock Holding History

Atria Investments’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,953
Closed -$128K – 794
2020
Q1 		$128K Sell
16,953
-18,866
-53% -$212K 0.01% 550
2019
Q4 		$556K Buy
+35,819
New +$361K 0.02% 747
2019
Q3 		– Sell
-22,915
Closed -$162K – 995
2019
Q2 		$162K Buy
22,915
+10,720
+88% +$160K 0.01% 927
2019
Q1 		$291K Buy
+12,195
New +$249K 0.01% 715
2018
Q4 		– Sell
-7,581
Closed -$201K – 1037
2018
Q3 		$201K Buy
+7,581
New +$172K 0.01% 940

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Atria Investments's MYOV Position: Q2 2020 in Review

Atria Investments sold out of Myovant Sciences Ltd. (MYOV) in Q2 2020, closing a stake of 16,953 shares — an estimated $128K sold.

Atria Investments first reported a position in MYOV in Q3 2018 and held it in 5 quarters. The position peaked at $556K in Q4 2019. 96 funds tracked by Wall St. Rank hold MYOV as of Q2 2020.

  • Atria Investments reported no remaining Myovant Sciences Ltd. position as of Q2 2020 after selling out during the quarter.
  • Atria Investments sold 16,953 Myovant Sciences Ltd. shares in Q2 2020, an estimated $128K.
  • Atria Investments first reported a position in Myovant Sciences Ltd. in Q3 2018 and held it in 5 quarters.
  • Atria Investments's Myovant Sciences Ltd. position peaked at $556K in Q4 2019.
  • 96 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.